Need for inclusion of high-risk populations and standardisation of immunogenicity outcomes in adult pneumococcal vaccine trials

Zitta Barrella Harboe*, Elisa Cordero, Conor Moran, Laura Kuijpers, Olivier Epaulard, Albert Vollaard

*Corresponding author af dette arbejde
OriginalsprogEngelsk
TidsskriftThe Lancet Infectious Diseases
Vol/bind25
Udgave nummer7
Sider (fra-til)e378-e379
ISSN1473-3099
DOI
StatusUdgivet - jul. 2025

Citationsformater